The clinical relevance of various methods of classifying ipsilateral breast tumour recurrence as either true local recurrence or new primary
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology
Link
https://link.springer.com/content/pdf/10.1007/s10549-022-06680-7.pdf
Reference16 articles.
1. Whelan T, Clark R, Roberts R, Levine M, Foster G (1994) Ipsilateral breast tumor recurrence post lumpectomy is predictive of subsequent mortality: results from a randomized trial. Investigators of the Ontario Clinical Oncology Group. Int J Rad Oncol Biol Phys 30:11–16
2. Haffty BG, Reiss M, Beinfield M, Fischer D, Ward B, McKhann C (1996) Ipsilateral breast tumor recurrence as a predictor of distant disease: Implications for systemic therapy at the time of local relapse. J Clin Oncol 14:52–57
3. Vicini FA, Kestin L, Huang R, Martinez A (2003) Does local recurrence affect the rate of distant metastases and survival in patients with early-stage breast carcinoma treated with breast-conserving therapy? Cancer 97:910–919
4. Laas E, Hamy AS, Michel AS, Panchbhaya N, Faron M et al (2019) Impact of time to local recurrence on the occurrence of metastasis in breast cancer patients treated with neoadjuvant chemotherapy: a random forest survival approach. PLoS ONE 14(1):e0208807
5. Fisher B, Anderson S, Fisher ER, Redmond C, Wickerham DL et al (1991) Significance of ipsilateral breast tumor recurrence after lumpectomy. Lancet 338:327–331
Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Do we need reshape rTNM staging system for ipsilateral breast tumor recurrence of breast cancer? A population-based, propensity score matched cohort study;Breast Cancer Research and Treatment;2024-05-10
2. Ipsilateral breast tumor recurrence after breast-conserving surgery: insights into biology and treatment;Breast Cancer Research and Treatment;2023-08-01
3. Comments on: The clinical relevance of various methods of classifying ipsilateral breast tumor recurrence as either true local recurrence or new primary;Breast Cancer Research and Treatment;2022-10-30
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3